StonvexLoading…
StonvexStonvexStonvexCore line items from VALU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $35.08M | $37.49M | $39.70M | $40.52M |
Operating Income | $5.99M | $9.14M | $11.47M | $10.80M |
Net Income | $20.69M | $19.02M | $18.07M | $23.82M |
EPS (Diluted) | $2.20 | $2.02 | $1.91 | $2.50 |
Total Assets | $144.53M | $136.03M | $131.08M | $128.74M |
Total Liabilities | $44.85M | $45.24M | $47.40M | $49.10M |
Cash & Equivalents | $34.08M | $4.39M | $7.59M | $29.70M |
Free Cash Flow OCF − CapEx | $20.07M | $17.92M | $18.15M | $24.64M |
Shares Outstanding | 9.42M | 9.43M | 9.46M | 9.54M |